TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9395279

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 809

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 809
Study: 7526096

Group type: EXPERIMENTAL
Intervention: Hepatic-artery infusion of floxuridine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional symptom palliation
Number of subjects: 100
Study: 3662274

Group type: EXPERIMENTAL
Intervention: Lovastatin 5 to 40 mg twice daily or 20 to 40 mg once daily in the evening
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 31848609

Group type: EXPERIMENTAL
Intervention: Whole walnuts diet (WD; 57-99 g/d walnuts; 2.7% ALA)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Walnut fatty acid-matched diet (WFMD; 2.6% ALA)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Oleic acid replaces ALA diet (ORAD; 0.4% ALA)
Number of subjects: 42
Study: 29122636

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 16791

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 16791

Group type: EXPERIMENTAL
Intervention: Patients with a history of falling (both treatments)
Number of subjects: 16791

Group type: COMPARATOR
Intervention: Apixaban vs Warfarin
Number of subjects: 16791
Study: 28042631

Group type: EXPERIMENTAL
Intervention: Wet cupping intervention (one session)
Number of subjects: 629

Group type: COMPARATOR
Intervention: Control group (ordinary treatment only)
Number of subjects: 629
Study: 25300690

Group type: EXPERIMENTAL
Intervention: L 1,2 group (N = 26)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: L 2,3 group (N = 29)
Number of subjects: 87

Group type: COMPARATOR
Intervention: L 3,4 group (N = 27)
Number of subjects: 87
Study: 23479319

Group type: EXPERIMENTAL
Intervention: 15 mg/kg sodium selenite and 30 mg/kg ascorbic acid every 24 h for 4 weeks
Number of subjects: 40
Study: 20368052

Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTI) during OLT
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 31
Study: 18757284

Group type: EXPERIMENTAL
Intervention: Treadmill exercise (T‐EX)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Stretching (CON)
Number of subjects: 71
Study: 16932894

Group type: EXPERIMENTAL
Intervention: Tonsillectomy plus pulse therapy (prednisolone, warfarin, dipyridamole, methylprednisolone pulse)
Number of subjects: 32

Group type: COMPARATOR
Intervention: PWDM (prednisolone, warfarin, dipyridamole, mizoribine)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tonsillectomy plus pulse therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: PWDM
Number of subjects: 32
Study: 15590588

Group type: EXPERIMENTAL
Intervention: Vision and hearing tests
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Vision tests only
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Hearing tests only
Number of subjects: 208

Group type: COMPARATOR
Intervention: Neither
Number of subjects: 208
Study: 10778867

Group type: EXPERIMENTAL
Intervention: Intralipid 20% with heparin (0.4 U/kg body weight/min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control infusion of saline (150 mmol/L)
Number of subjects: 8
Study: 9068307

Group type: EXPERIMENTAL
Intervention: Standard physiotherapy (SPT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Modified physiotherapy (MPT)
Number of subjects: 20
Study: 8513615

Group type: EXPERIMENTAL
Intervention: Intensive intrapartum monitoring
Number of subjects: 13000
Study: 2871784

Group type: EXPERIMENTAL
Intervention: Bevantolol 100 to 400 mg/day
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 30380336

Group type: EXPERIMENTAL
Intervention: Very-old patient condition
Number of subjects: 114

Group type: COMPARATOR
Intervention: Middle-aged patient condition
Number of subjects: 114
Study: 30938064

Group type: EXPERIMENTAL
Intervention: CPAP with heated humidification (ThermoSmart)
Number of subjects: 40

Group type: COMPARATOR
Intervention: CPAP without heated humidification
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preference for ThermoSmart ON
Number of subjects: 40
Study: 29231498

Group type: EXPERIMENTAL
Intervention: Abdominal acupuncture therapy applied to Zhongwan (CV 12), Xiawan (CV 10), Qihai (CV 6), Guanyuan (CV 4), Tianshu (ST 25) and Shuidao (ST 28), once a day, 5 times a week for 3 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Healthcare guide and adjustment on diet and physical exercise
Number of subjects: 86
Study: 25521911

Group type: EXPERIMENTAL
Intervention: Coping strategies (expressing positive emotions, positive reframing of the cancer experience, cultivating a sense of peace and meaning)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Cultivating a sense of peace and meaning
Number of subjects: 281
Study: 23461703

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Supportive Listening
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) and Supportive Listening
Number of subjects: 30
Study: 21226864

Group type: EXPERIMENTAL
Intervention: Active warming
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard care (sheet cover)
Number of subjects: 150
Study: 18074229

Group type: EXPERIMENTAL
Intervention: Pearl barley with high beta-glucan content (7.0 g beta-glucan per day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Rice (placebo group)
Number of subjects: 44
Study: 16478760

Group type: EXPERIMENTAL
Intervention: Monophasic oral contraceptives with 20, 30 or 50 microg/day estrogen
Number of subjects: 507
Study: 15451891

Group type: EXPERIMENTAL
Intervention: Population management intervention using PopMan software by a nurse practitioner
Number of subjects: 3079

Group type: EXPERIMENTAL
Intervention: Population management intervention
Number of subjects: 3079

Group type: COMPARATOR
Intervention: Usual care (control clinics)
Number of subjects: 3079
Study: 11425369

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 425

Group type: COMPARATOR
Intervention: Formula feeding
Number of subjects: 425
Study: 8995739

Group type: EXPERIMENTAL
Intervention: Renal biopsy
Number of subjects: 88
Study: 8295082

Group type: EXPERIMENTAL
Intervention: Parental nonprocedural talk (distraction)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Parental reassurance
Number of subjects: 42

Group type: COMPARATOR
Intervention: Minimal‐treatment control
Number of subjects: 42
Study: 3812339

Group type: EXPERIMENTAL
Intervention: Human milk
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Commercial formula
Number of subjects: 35
Study: 31777325

Group type: EXPERIMENTAL
Intervention: Chronic Opioid Therapy (COT) tapering trial
Number of subjects: 190
Study: 28347377

Group type: EXPERIMENTAL
Intervention: Personal Model of Resilience (PMR) intervention
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 25569708

Group type: EXPERIMENTAL
Intervention: Buprenorphine (0.2 mg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 23544481

Group type: EXPERIMENTAL
Intervention: Psychometric measures of leader self-complexity
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Quantitative electroencephalogram (qEEG) profiles of leader self-complexity
Number of subjects: 103
Study: 20651023

Group type: EXPERIMENTAL
Intervention: Cysteine plasma levels in patients with OSA
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cysteine plasma levels in control subjects
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cysteine plasma levels in lean patients with OSA
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cysteine plasma levels in lean control subjects
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cysteine plasma levels after 6 months of CPAP therapy
Number of subjects: 75
Study: 19556381

Group type: EXPERIMENTAL
Intervention: iopamidol
Number of subjects: 294

Group type: COMPARATOR
Intervention: iodixanol
Number of subjects: 294
Study: 17846331

Group type: EXPERIMENTAL
Intervention: TP10 (5 mg/kg dose as a 30-minute intravenous infusion before surgery)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo (as a 30-minute intravenous infusion before surgery)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: TP10
Number of subjects: 297
Study: 15077009

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 1686
Study: 12541863

Group type: EXPERIMENTAL
Intervention: Local group (local injected with IL‐2 + radiotherapy + chemotherapy)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: General group (ivdrip with IL‐2 + radiotherapy + chemotherapy)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Convention group (radiotherapy + chemotherapy)
Number of subjects: 90
Study: 9555769

Group type: EXPERIMENTAL
Intervention: Intravenous beta-blocker administration
Number of subjects: 8326

Group type: EXPERIMENTAL
Intervention: Ejection fraction ≤ 40%
Number of subjects: 8326

Group type: EXPERIMENTAL
Intervention: Killip class > I
Number of subjects: 8326

Group type: EXPERIMENTAL
Intervention: Early intravenous beta-blocker administration
Number of subjects: 8326

Group type: COMPARATOR
Intervention: Oral beta-blocker therapy
Number of subjects: 8326

Group type: COMPARATOR
Intervention: Nitrates and lisinopril treatment
Number of subjects: 8326
Study: 7923668

Group type: EXPERIMENTAL
Intervention: Passive head-up tilt at various angles (15 degrees, 30 degrees, 45 degrees, 60 degrees, 90 degrees)
Number of subjects: 22
Study: 2499700

Group type: EXPERIMENTAL
Intervention: DPT - IPV (combined DPT - enhanced injectable polio vaccine)
Number of subjects: 200

Group type: COMPARATOR
Intervention: DPT (Conventional Schedule with 3 doses of oral polio vaccine and 2 doses of DPT)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: DPT - IPV or DPT vaccine alone
Number of subjects: 200
Study: 1097479

Group type: EXPERIMENTAL
Intervention: Benapryzine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Trihexyphenidyl
Number of subjects: 10
Study: 30890102

Group type: EXPERIMENTAL
Intervention: Random biopsies (RB) + targeted biopsies (TB)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Only targeted biopsies (TB)
Number of subjects: 130
Study: 28719572

Group type: EXPERIMENTAL
Intervention: Constraint-Induced Aphasia Therapy (CIAT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 24
Study: 26405698

Group type: EXPERIMENTAL
Intervention: Aloe barbadensis Mill. Extract (AVH200®)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 23203909

Group type: EXPERIMENTAL
Intervention: Self-gripping mesh (Parietene Progrip(®))
Number of subjects: 334

Group type: COMPARATOR
Intervention: Sutured mesh
Number of subjects: 334
Study: 22126550

Group type: EXPERIMENTAL
Intervention: Taxotere plus poldine intravenous chemotherapy (A1)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Taxotere intravenous chemotherapy combined with poldine intraperitoneal chemotherapy (A2)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus poldine intravenous chemotherapy (B1)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Paclitaxel intravenous chemotherapy combined with poldine intraperitoneal chemotherapy (B2)
Number of subjects: 27
Study: 19508157

Group type: EXPERIMENTAL
Intervention: Intermittent IL-2 therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 130
Study: 16564803

Group type: EXPERIMENTAL
Intervention: Bilateral lateral rectus (BLR) recessions
Number of subjects: 124

Group type: COMPARATOR
Intervention: Unilateral recess-resect (RR) procedure on the nondominant eye
Number of subjects: 124
Study: 12968319

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study: 10700435

Group type: EXPERIMENTAL
Intervention: Arthrocentesis (synovial fluid aspiration) before injecting 20 mg triamcinolone hexacetonide
Number of subjects: 147

Group type: COMPARATOR
Intervention: No arthrocentesis before injecting 20 mg triamcinolone hexacetonide
Number of subjects: 147
Study: 9305485

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day
Number of subjects: 16
Study: 8419599

Group type: EXPERIMENTAL
Intervention: Prophylactic surfactant at birth
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Rescue surfactant after clinical diagnosis of respiratory distress syndrome
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 2995755

Group type: EXPERIMENTAL
Intervention: Radiation therapy under hyperbaric oxygenation (HBO)
Number of subjects: 120
Study: 29975804

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chemical neurolysis (alcohol)
Number of subjects: 60
Study: 27130272

Group type: EXPERIMENTAL
Intervention: Stepped collaborative care intervention targeting PTSD and comorbidity
Number of subjects: 960

Group type: COMPARATOR
Intervention: Enhanced usual care (Control)
Number of subjects: 960
Study: 23334623

Group type: EXPERIMENTAL
Intervention: Joint aspiration
Number of subjects: 167

Group type: COMPARATOR
Intervention: No aspiration (Control)
Number of subjects: 167
Study: 22019031

Group type: EXPERIMENTAL
Intervention: Discontinuation of low dose chemoprophylaxis
Number of subjects: 176
Study: 15640321

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg daily for 4 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 14
Study: 12370885

Group type: EXPERIMENTAL
Intervention: Hands-free environmental control system (ECS)
Number of subjects: 10
Study: 9639076

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg methylphenidate
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg methylphenidate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 7807300

Group type: EXPERIMENTAL
Intervention: Bovine surfactant therapy
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 119
Study: 2775613

Group type: EXPERIMENTAL
Intervention: Quinidine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Dextromethorphan
Number of subjects: 5

Group type: COMPARATOR
Intervention: Low affinity component
Number of subjects: 5
Study: 57131

Group type: EXPERIMENTAL
Intervention: Aqueous grass extract
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Water-soluble timothy (WST) in alginate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injections of antigen D in alginate
Number of subjects: 0
Study: 29627897

Group type: EXPERIMENTAL
Intervention: Cefiderocol 2 g every 8 h with 3-h infusion (3, 6, and 9 doses with furosemide, metformin, and rosuvastatin respectively)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Furosemide 20 mg
Number of subjects: 39

Group type: COMPARATOR
Intervention: Metformin 1000 mg
Number of subjects: 39

Group type: COMPARATOR
Intervention: Rosuvastatin 10 mg
Number of subjects: 39
Study: 26761585

Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study: 24659610

Group type: EXPERIMENTAL
Intervention: Dietary supplements (10 supplements daily including 100 mg resveratrol, 800 mg each of green, black, and white tea extract, 250 mg pomegranate extract, 650 mg quercetin, 500 mg acetyl-l-carnitine, 600 mg lipoic acid, 900 mg curcumin, 1 g sesamin, 1.7 g cinnamon bark extract, and 1.0 g fish oil)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (daily multivitamin/mineral supplement)
Number of subjects: 56
Study: 22551128

Group type: EXPERIMENTAL
Intervention: Low-dose radioiodine (1.1 GBq [30 mCi])
Number of subjects: 421

Group type: COMPARATOR
Intervention: High-dose radioiodine (3.7 GBq [100 mCi])
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Thyrotropin alfa
Number of subjects: 421

Group type: COMPARATOR
Intervention: Thyroid hormone withdrawal
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Low-dose radioiodine plus thyrotropin alfa
Number of subjects: 421

Group type: COMPARATOR
Intervention: High-dose radioiodine plus thyroid hormone withdrawal
Number of subjects: 421

Group type: COMPARATOR
Intervention: High-dose radioiodine plus thyrotropin alfa
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Low-dose radioiodine
Number of subjects: 421

Group type: COMPARATOR
Intervention: High-dose radioiodine
Number of subjects: 421
Study: 20418185

Group type: EXPERIMENTAL
Intervention: Nondistressed married participants
Number of subjects: 255

Group type: COMPARATOR
Intervention: Distressed married participants
Number of subjects: 255

Group type: COMPARATOR
Intervention: Unmarried participants
Number of subjects: 255
Study: 18386209

Group type: EXPERIMENTAL
Intervention: Interventions for suicidal youths; specific interventions not detailed in the abstract.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care treatments; specific treatments not detailed in the abstract.
Number of subjects: 0
Study: 15970422

Group type: EXPERIMENTAL
Intervention: Training program for developing communication skills of health professionals (physicians, physiotherapists, and nurses) and reorganization of patient information schemes.
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Self-administered breathing exercises (intermediary outcome parameter).
Number of subjects: 199

Group type: COMPARATOR
Intervention: Not available.
Number of subjects: 199
Study: 12947065

Group type: EXPERIMENTAL
Intervention: BAY 12‐9566 800 mg orally bid continuously
Number of subjects: 277

Group type: COMPARATOR
Intervention: gemcitabine 1,000 mg/m2 intravenously on specified days
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Quality-of-life analysis
Number of subjects: 277
Study: 10817010

Group type: EXPERIMENTAL
Intervention: Continuous hormone replacement therapy alone (Group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of a half dose hormone replacement therapy and anxiolytic drug (Group B)
Number of subjects: 100
Study: 8865765

Group type: EXPERIMENTAL
Intervention: A/A gain settings of 0.75 and 1.0
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: D/A gain settings of 0.5 cm/degree and 0.67 cm/degree
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: D/A gain settings
Number of subjects: 0
Study: 1508382

Group type: EXPERIMENTAL
Intervention: Calcium folinate (Citofolin Bracco S.p.A.) 15 mg/day per os starting from the 12th or 20th week of gestation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 0
Study: 6396639

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Long follow-up and nicotine gum
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Short follow-up and nicotine gum
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Long follow-up and no gum
Number of subjects: 151

Group type: COMPARATOR
Intervention: Short follow-up and no gum
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Long follow-up
Number of subjects: 151
Study: 31208092

Group type: EXPERIMENTAL
Intervention: Snack condition (10% of 24 h energy intake)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Meal condition (30% of 24 h energy intake)
Number of subjects: 44

Group type: COMPARATOR
Intervention: No Eating condition (no food during the night)
Number of subjects: 44
Study: 29446069

Group type: EXPERIMENTAL
Intervention: ACT-541468 (5-200 mg single oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACT-541468 (≥25 mg)
Number of subjects: 0
Study: 27777279

Group type: EXPERIMENTAL
Intervention: Alirocumab 75/150 mg every 2 weeks
Number of subjects: 4974

Group type: EXPERIMENTAL
Intervention: Ezetimibe
Number of subjects: 4974

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4974
Study: 24412583

Group type: EXPERIMENTAL
Intervention: Exercise (45 min)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control condition (45 min)
Number of subjects: 50
Study: 22897508

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Propofol with alfentanil
Number of subjects: 165
Study: 20621444

Group type: EXPERIMENTAL
Intervention: Computerized visual perception and visual-motor integration training (8 sessions) with a home training program
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional handwriting training by teachers (remedial handwriting exercises)
Number of subjects: 26
Study: 17917556

Group type: EXPERIMENTAL
Intervention: Venlafaxine (mean dose 165 mg/day, SD=73.8; range 75-300 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Paroxetine (mean dose 26 mg/day, SD=15.04; range 10-60 mg)
Number of subjects: 30
Study: 16047553

Group type: EXPERIMENTAL
Intervention: Herbal preparations
Number of subjects: 3160
Study: 12381630

Group type: EXPERIMENTAL
Intervention: Heart failure patients
Number of subjects: 80

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 80
Study: 10367513

Group type: EXPERIMENTAL
Intervention: B.A.R. (Biofragmentable Anastomosis Ring)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: GLA stapling device
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Manual suture with interrupted stitches double layer (vicryl)
Number of subjects: 45
Study: 7480525

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (four different compounds)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (during the run-in period)
Number of subjects: 49
Study: 2265308

Group type: EXPERIMENTAL
Intervention: herbal yeast food supplement
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 299462

Group type: EXPERIMENTAL
Intervention: Prostaglandin (20 mg) and hypertonic saline (NaCl 5 and 10 g) with oxytocin
Number of subjects: 385
Study: 31724971

Group type: EXPERIMENTAL
Intervention: Parental involvement in manual reduction (physician's and parent's finger on the patient's radial head)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Physician's finger only on the patient's radial head (control group)
Number of subjects: 150
Study: 31801605

Group type: EXPERIMENTAL
Intervention: Gain-framed messages (GF)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Loss-framed messages (LF)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Routine education (Control)
Number of subjects: 96
Study: 27299887

Group type: EXPERIMENTAL
Intervention: DCS therapy (docetaxel at 40 mg/m2, cisplatin at 60 mg/m2 on day 1, S-1 at 40 mg/m2 twice daily for 2 weeks) followed by gastrectomy with D2 plus para-aortic nodal dissection
Number of subjects: 52